Ipamorelin is a selective growth hormone secretagogue extensively studied in laboratory and preclinical research for its role in ghrelin receptor (GHS-R1a) activation and stimulation of endogenous growth hormone (GH) release. Ipamorelin 10mg is commonly utilized in controlled research environments to investigate GH pulsatility, endocrine signaling pathways, and hypothalamic–pituitary axis regulation.
 
Research applications frequently focus on Ipamorelin’s targeted interaction with ghrelin receptors, leading to downstream growth hormone release and IGF-1 pathway modulation, while maintaining minimal interaction with cortisol or prolactin signaling in experimental models. This selective mechanism makes Ipamorelin particularly useful in studies requiring precise evaluation of GH-related pathways without broader endocrine disruption.
 
Additional investigations explore its role in metabolic regulation, tissue recovery models, and energy utilization pathways, making it a widely utilized compound in growth hormone and recovery-focused research protocols. The 10mg format provides added flexibility for extended research protocols or higher-volume experimental applications.
 
This high-purity 10mg formulation is manufactured to strict laboratory standards and intended exclusively for analytical testing, in-vitro studies, and experimental research applications.
 
For research use only. Not for human consumption.
 
See product pictures for Certificates of Analysis.